Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025)
Tyra Biosciences (TYRA) reported Accumulated Depreciation of $1.4 million for Q1 2025, up 50.43% on a YoY basis from $926000.0 in Q1 2024, and up 8.74% quarter-over-quarter from $1.3 million in Q4 2024.
Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Tyra Biosciences has reported Accumulated Depreciation for 6 years, with the latest figure at $1.4 million in Q1 2025.
- For the quarter ending Q1 2025, Accumulated Depreciation rose 50.43% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2025 stood at $1.4 million (up 50.43% YoY), and the FY2024 full-year result was $1.3 million, up 58.74% from the prior year.
- Accumulated Depreciation for Q1 2025 stood at $1.4 million, up from $1.3 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $1.4 million in Q1 2025, with the low at $119000.0 in Q3 2021.
- Historically, Accumulated Depreciation has averaged $678466.7 across 5 years, with a median of $629000.0 in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation soared 293.02% — and 2025, when it jumped 50.43%.
- Tyra Biosciences' Accumulated Depreciation stood at $169000.0 in 2021, then surged by 172.78% to $461000.0 in 2022, then jumped by 75.05% to $807000.0 in 2023, then soared by 58.74% to $1.3 million in 2024, then increased by 8.74% to $1.4 million in 2025.
- The last three Accumulated Depreciation figures came in at $1.4 million (Q1 2025), $1.3 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 926,000.00 |
| Dec 31, 2023 | 807,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Jun 30, 2023 | 629,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 233,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Dec 31, 2020 | 43,000.00 |